المقدمة
توفر هذه الصفحة تحليلاً شاملاً لتاريخ التداول الداخلي المعروف لشركة Kevin T Conroy. المطلعون هم المسؤولين أو مدراء أو مستثمرين مهمين في الشركة. من غير القانوني أن يقوم المطلعون بإجراء عمليات تداول في شركاتهم بناءً على معلومات محددة وغير عامة. وهذا لا يعني أنه من غير القانوني بالنسبة لهم إجراء أي صفقات تجارية في شركاتهم الخاصة. ومع ذلك، يجب عليهم الإبلاغ عن جميع الصفقات إلى هيئة الأوراق المالية والبورصة عبر النموذج 4. وعلى الرغم من هذه القيود، تشير الأبحاث الأكاديمية إلى أن المطلعين - بشكل عام - يميلون إلى التفوق على السوق في شركاتهم الخاصة.
متوسط ربحية التبادل التجاري
متوسط ربحية التجارة هو متوسط عائد جميع مشتريات السوق المفتوحة التي قام بها المطلعون في السنوات الثلاث الماضية. لحساب ذلك، نقوم بفحص كل عملية شراء غير مخطط لها في السوق المفتوحة يقوم بها المطلعون، باستثناء جميع الصفقات التي تم وضع علامة عليها كجزء من خطة التداول 10b5-1. نقوم بعد ذلك باحتساب متوسط أداء تلك الصفقات على مدار 3 و6 و12 شهرًا، مع متوسط كل من هذه الفترات لإنشاء مقياس أداء نهائي لكل صفقة. وأخيرًا، نقوم بحساب متوسط جميع مقاييس الأداء لحساب مقياس الأداء للمطلعين على بواطن الأمور. تتضمن هذه القائمة فقط المطلعين الذين أجروا ثلاث صفقات على الأقل في العامين الماضيين.
إذا كانت ربحية التجارة الداخلية هذه "غير متاحة"، فإما أن الشخص المطلع إما لم يقم بأي عمليات شراء في السوق المفتوحة في السنوات الثلاث الماضية، أو أن الصفقات التي قام بها حديثة جدًا بحيث لا يمكن احتساب مقياس أداء موثوق به.
تكرار التحديث: يومياً
الشركات التي لديها مناصب داخلية مُبلغ عنها
تشير تصريحات هيئة الأوراق المالية والبورصة إلى أن Kevin T Conroy قد أبلغ عن ممتلكات أو تداولات في الشركات التالية:
سند مالي | العنوان | أحدث الحيازات المبلغ عنها |
---|---|---|
US:ALGN / Align Technology, Inc. | Director | ١٬٨٠٨ |
US:EXAS / Exact Sciences Corporation | President and CEO, Director | ٠ |
US:ADPT / Adaptive Biotechnologies Corporation | Director | ٢٢٬٩٦٨ |
US:EPZM / Epizyme Inc | Director | ٠ |
US:US83444K1135 / SomaLogic Inc | Director | ٠ |
Director | ٠ |
كيفية تفسير الرسوم البيانية
توضح الرسوم البيانية التالية أداء أسهم الأوراق المالية بعد كل عملية تداول غير مخطط لها في السوق المفتوحة يتم إجراؤها بواسطة Kevin T Conroy. التجارة غير المخطط لها هي الصفقات التي لم يتم إجراؤها كجزء من خطة التداول 10b5-1. يتم رسم أداء السهم كنسبة مئوية من التغير التراكمي في سعر السهم. على سبيل المثال، إذا تم إجراء تداول من الداخل في 1 يناير 2019، فسيظهر الرسم البياني النسبة المئوية للتغير اليومي للأوراق المالية حتى يومنا هذا. إذا ارتفع سعر السهم من 10 دولارات إلى 15 دولارًا خلال هذا الوقت، فإن نسبة التغير التراكمي في سعر السهم ستكون 50%. التغيير في السعر من 10 دولارات إلى 20 دولارًا سيكون 100%، والتغيير في السعر من 10 دولارات إلى 5 دولارات سيكون -50%.
في النهاية، نحاول تحديد مدى ارتباط تداولات المطلعين الداخليين بالعوائد الزائدة (الإيجابية أو السلبية) في سعر السهم من أجل معرفة ما إذا كان المطلعون الداخليون يقومون بتوقيت تداولاتهم للاستفادة من المعلومات الداخلية. خذ بعين الاعتبار الموقف الذي كان يقوم فيه أحد المطلعين بذلك. في هذه الحالة، نتوقع إما (أ) عوائد إيجابية بعد الشراء، أو (ب) عوائد سلبية بعد البيع. في حالة (أ)، سيظهر مخطط الشراء سلسلة من المنحنيات المائلة للأعلى، مما يشير إلى عوائد إيجابية بعد كل معاملة شراء. في حالة (ب)، سيظهر مخطط البيع سلسلة من المنحنيات المائلة للأسفل، مما يشير إلى عوائد سلبية بعد كل معاملة بيع.
رغم ذلك، هذا وحده لا يكفي لاستخلاص النتائج. على سبيل المثال، إذا كان سعر سهم الشركة في حالة ارتفاع غير دوري على مدى سنوات عديدة، فإننا نتوقع أن تكون جميع المخططات بعد الشراء مائلة نحو الأعلى. وعلى نحو مماثل، فإن الانحدارات غير الدورية على مدى سنوات عديدة من شأنها أن تؤدي إلى انحدار في مخططات ما بعد التجارة. لا يشير أي من هذه المخططات إلى نشاط تداول داخلي.
سيكون المؤشر الأقوى هو الحالة التي يكون فيها سعر السهم دوريًا للغاية، وكانت هناك إشارات إيجابية في مخطط الشراء ومؤامرات سلبية على مخطط البيع. سيكون هذا الموقف يوحي بشكل كبير بوجود شخص من الداخل كان يقوم بتوقيت التداولات لصالحه المالي.
المشتريات الداخلية ADPT / Adaptive Biotechnologies Corporation - تحليل الأرباح على المدى القصير
في هذا القسم، نقوم بتحليل ربحية كل عملية شراء داخلية غير مخطط لها في السوق المفتوحة تم إجراؤها في ADPT / Adaptive Biotechnologies Corporation. يساعد هذا التحليل على فهم ما إذا كان المطلعين على بواطن الأمور يحققون عوائد غير طبيعية باستمرار، ويستحقون المتابعة. هذا التحليل مخصص لمدة عام واحد بعد كل صفقة، والنتائج نظرية.
يوضح الجدول التالي أحدث عمليات الشراء في السوق المفتوحة والتي لم تكن جزءًا من خطة التداول التلقائية.
تاريخ التبادل | المؤشر | المطلع | الأسهم المبلغ عنها |
السعر المعلن عنه |
الأسهم المعدلة |
السعر المعدل |
أساس التكلفة | أيام إلى الحد الأقصى |
السعر بالحد الأقصى |
الحد الأقصى للربح($) |
الحد الأقصى للعائد (%) |
---|---|---|---|---|---|---|---|
لا توجد عمليات تداول معروفة غير مخطط لها في السوق المفتوحة لهذه المجموعة الداخلية والأمنية |
السعر المعدل هو السعر المعدل حسب التقسيم. الأسهم المعدلة هي الأسهم المعدلة حسب التقسيم.
المبيعات الداخلية ADPT / Adaptive Biotechnologies Corporation - تحليل الخسائر على المدى القصير
في هذا القسم، نقوم بتحليل تجنب الخسارة على المدى القصير لكل عملية بيع داخلية غير مخطط لها في السوق المفتوحة تم إجراؤها في ADPT / Adaptive Biotechnologies Corporation. قد يشير النمط الثابت لتجنب الخسارة إلى أن معاملات البيع المستقبلية قد تتنبأ بانخفاض الأسعار. هذا التحليل مخصص لمدة عام واحد بعد كل صفقة، والنتائج نظرية.
يوضح الجدول التالي أحدث مبيعات السوق المفتوحة التي لم تكن جزءًا من خطة التداول التلقائية.
تاريخ التبادل | المؤشر | المطلع | الأسهم المبلغ عنها |
السعر المعلن عنه |
الأسهم المعدلة |
السعر المعدل |
أساس التكلفة | عدد الأيام حتى الحد الأدنى |
السعر بالحد الأدنى |
أقصى خسارة تم تجنبها ($) |
أقصى خسارة تم تجنبها ($) |
---|---|---|---|---|---|---|---|
لا توجد عمليات تداول معروفة غير مخطط لها في السوق المفتوحة لهذه المجموعة الداخلية والأمنية |
السعر المعدل هو السعر المعدل حسب التقسيم. الأسهم المعدلة هي الأسهم المعدلة حسب التقسيم.
تاريخ التداول من الداخل
يعرض هذا الجدول القائمة الكاملة للتداولات الداخلية التي أجراها Kevin T Conroy كما تم الكشف عنها للجنة الأوراق المالية (SEC).
تاريخ الملف | تاريخ العملية | النموذح | المؤشر | سند مالي | الرمز | الأسهم | الأسهم المتبقية | نسبة التغير |
سعر السهم |
تاريخ العملية |
القيمة المتبقية |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-22 |
|
4 | ALGN |
ALIGN TECHNOLOGY INC
Common Stock |
M - Exercise | ١٬١٤٨ | ١٬٨٠٨ | ١٧٣٫٩٤ | ||||
2025-04-29 |
|
5/A | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٢٢٬٠٦٣ | ٠ | ١٠٠٫٠٠ | ||||
2025-04-29 |
|
5/A | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٤٣٬١٢٦ | ٢٢٬٠٦٣ | ٦٦٫١٦ | ||||
2025-04-29 |
|
5/A | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٤٣٬١٢٦ | ٨٩٣٬٨١٨ | ٥٫٠٧ | ||||
2025-04-29 |
|
5/A | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٢٨٬٦٦٠ | ٨٥٠٬٦٩٢ | ٣٫٢٦ | ||||
2025-04-29 |
|
5 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ١٦٣٬٠٠٠ | ٦٠٢٬١٢٠ | ٢١٫٣٠ | ||||
2025-04-29 |
|
5 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٧٤٬٥٩٩ | ٧٧٩٬٩٤٤ | ٨٫٧٣ | ||||
2025-03-10 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
F - Taxes | ٤٨٬٩٢٩ | ١٬١٥٤٬٣٤٠ | ٤٫٠٧ | ٤٧٫٠٦ | ٢٬٣٠٢٬٥٩٩ | ٥٤٬٣٢٣٬٢٤٠ | |
2025-03-10 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٦٦٬٧٢٣ | ١٬٢٠٣٬٢٦٩ | ٥٫٨٧ | ٢٢٫٣٨ | ١٬٤٩٣٬٢٦١ | ٢٦٬٩٢٩٬١٦٠ | |
2025-03-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
F - Taxes | ١٠٬٤١٩ | ١٬١٣٦٬٥٤٦ | ٠٫٩١ | ٤٧٫٨٢ | ٤٩٨٬٢٣٧ | ٥٤٬٣٤٩٬٦٣٠ | |
2025-03-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٢٬١٦٧ | ١٬١٤٦٬٩٦٥ | ١٫٩٧ | ||||
2025-03-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
F - Taxes | ٨٬٥٢٨ | ١٬١٢٤٬٧٩٨ | ٠٫٧٥ | ٤٧٫٨٢ | ٤٠٧٬٨٠٩ | ٥٣٬٧٨٧٬٨٤٠ | |
2025-03-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٨٬١٤٣ | ١٬١٣٣٬٣٢٦ | ١٫٦٣ | ||||
2025-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
F - Taxes | ٦٬١٩٥ | ١٬١١٥٬١٨٣ | ٠٫٥٥ | ٥١٫٢٨ | ٣١٧٬٦٨٠ | ٥٧٬١٨٦٬٥٨٤ | |
2025-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٣٬١٨٠ | ١٬١٢١٬٣٧٨ | ١٫١٩ | ||||
2025-02-21 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
F - Taxes | ٢١٬١٤٠ | ١٬١٠٨٬١٩٨ | ١٫٨٧ | ٥٠٫٤٨ | ١٬٠٦٧٬١٤٧ | ٥٥٬٩٤١٬٨٣٥ | |
2025-02-21 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٤٨٬٠٤٤ | ١٬١٢٩٬٣٣٨ | ٤٫٤٤ | ||||
2025-02-21 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
F - Taxes | ٣٬٢٧١ | ١٬٠٨١٬٢٩٤ | ٠٫٣٠ | ٤٩٫٦٣ | ١٦٢٬٣٤٠ | ٥٣٬٦٦٤٬٦٢١ | |
2025-02-21 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٠٬٣٧٤ | ١٬٠٨٤٬٥٦٥ | ٠٫٩٧ | ||||
2024-11-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
P - Purchase | ١٩٬٥٠٠ | ١٬٠٧٤٬١٩١ | ١٫٨٥ | ٥١٫٣٥ | ١٬٠٠١٬٣٢٥ | ٥٥٬١٥٩٬٧٠٨ | |
2024-05-24 |
|
4 | ALGN |
ALIGN TECHNOLOGY INC
Common Stock |
M - Exercise | ٦٦٠ | ٦٦٠ | |||||
2024-05-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٬١٥٥ | ١٬١٥٦٬١٩١ | ٠٫١٠ | ٦٠٫١٥ | ٦٩٬٤٧٣ | ٦٩٬٥٤٤٬٨٨٩ |
2024-05-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٧٠٨ | ١٬١٥٧٬٣٤٦ | ٠٫٠٦ | ٣٠٫٠٢ | ٢١٬٢٥٤ | ٣٤٬٧٤٣٬٥٢٧ | |
2024-05-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٢٬٤٨٩ | ١٬١٥٦٬٦٣٨ | ٠٫٢٢ | ||||
2024-03-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٨٬٢٧١ | ١٬٢٩٩٬٤٩٦ | ٠٫٦٣ | ٥٩٫٣٢ | ٤٩٠٬٦٣٦ | ٧٧٬٠٨٦٬١٠٣ |
2024-03-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٨٬١٤٣ | ١٬٣٠٧٬٧٦٧ | ١٫٤١ | ||||
2024-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٦٬٢٦٣ | ١٬٢٨٩٬٦٢٤ | ٠٫٤٨ | ٥٦٫٨٩ | ٣٥٦٬٣٠٢ | ٧٣٬٣٦٦٬٧٠٩ |
2024-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٣٬١٨١ | ١٬٢٩٥٬٨٨٧ | ١٫٠٣ | ||||
2024-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
F - Taxes | ٦١٬٥٦٠ | ١٬٢٨٢٬٧٠٦ | ٤٫٥٨ | ٥٧٫٥٣ | ٣٬٥٤١٬٥٤٧ | ٧٣٬٧٩٤٬٠٧٦ | |
2024-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٠٢٬٨٣٧ | ١٬٣٤٤٬٢٦٦ | ٨٫٢٨ | ١٣٫٩٦ | ١٬٤٣٥٬٦٠٥ | ١٨٬٧٦٥٬٩٥٣ | |
2024-02-23 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١١٬٥٦٥ | ١٬٢٤١٬٤٢٩ | ٠٫٩٢ | ٥٩٫٧٨ | ٦٩١٬٣٥٦ | ٧٤٬٢١٢٬٦٢٦ |
2024-02-23 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٢٣٬٢٣٨ | ١٬٢٥٢٬٩٩٤ | ١٫٨٩ | ||||
2024-02-22 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٤٬٩٧٥ | ١٬٢٢٩٬٧٥٦ | ٠٫٤٠ | ٦١٫٥٠ | ٣٠٥٬٩٦٢ | ٧٥٬٦٢٩٬٩٩٤ |
2024-02-22 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٠٬٣٧٤ | ١٬٢٣٤٬٧٣١ | ٠٫٨٥ | ||||
2024-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٤٬٧٩١ | ١٬٢٢٤٬٣٥٧ | ١٫١٩ | ٦١٫٤٣ | ٩٠٨٬٦١١ | ٧٥٬٢١٢٬٢٥١ |
2024-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣١٬١٣٣ | ١٬٢٣٩٬١٤٨ | ٢٫٥٨ | ||||
2024-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٧٠٩ | ١٬٢٠٨٬٠١٥ | ٠٫٠٦ | ٣٠٫٠٢ | ٢١٬٢٨٤ | ٣٦٬٢٦٤٬٦١٠ | |
2023-03-08 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | ١٤٬٧٧٥ | ٢٢٬٩٦٨ | ١٨٠٫٣٤ | ||||
2023-03-01 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٠٬٤١٦ | ١٬٢٠٧٬٣٠٦ | ٠٫٨٦ | ٦١٫١٢ | ٦٣٦٬٦٢٦ | ٧٣٬٧٩٠٬٥٤٣ |
2023-03-01 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٩٬٣١٢ | ١٬٢١٧٬٧٢٢ | ٠٫٧٧ | ||||
2023-03-01 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٣٬١٨٠ | ١٬٢٠٨٬٤١٠ | ١٫١٠ | ||||
2023-02-23 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٤٬٧٦٤ | ١٬١٩٥٬٢٣٠ | ٠٫٤٠ | ٦٢٫٧٢ | ٢٩٨٬٧٩٨ | ٧٤٬٩٦٤٬٨٢٦ |
2023-02-23 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٠٬٣٧٤ | ١٬١٩٩٬٩٩٤ | ٠٫٨٧ | ||||
2023-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ١٤٬٦١٧ | ١٬١٨٩٬٦٢٠ | ١٫٢١ | ٦٥٫٥٩ | ٩٥٨٬٧٢٩ | ٧٨٬٠٢٧٬١٧٦ | |
2023-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣١٬١٣٢ | ١٬٢٠٤٬٢٣٧ | ٢٫٦٥ | ||||
2023-02-14 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٤٬٥٢٧ | ١٬١٧٣٬١٠٥ | ٠٫٣٨ | ٦٤٫٥٥ | ٢٩٢٬٢١٨ | ٧٥٬٧٢٣٬٩٢٨ |
2023-02-14 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٩٬٧٠٥ | ١٬١٧٧٬٦٣٢ | ٠٫٨٣ | ||||
2022-08-16 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
D - Sale to Issuer | ٨٬٩٩٤ | ٠ | ١٠٠٫٠٠ | ||||
2022-08-16 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
D - Sale to Issuer | ٥٣٬٣٢٤ | ٨٬٩٩٤ | ٨٥٫٥٧ | ||||
2022-07-06 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٧ | ١٬١٦٧٬٩٢٧ | ٠٫٠٠ | ٤٠٫٧٥ | ٢٨٥ | ٤٧٬٥٩٣٬٠٢٥ |
2022-07-06 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٣٢٨ | ١٬١٦٧٬٩٣٤ | ٠٫٠٣ | ٤٧٫٤١ | ١٥٬٥٥٠ | ٥٥٬٣٧١٬٧٥١ | |
2022-07-05 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ١٠٬٢٠٤ | ٦٢٬٣١٨ | ١٩٫٥٨ | ١٫٤٧ | ١٥٬٠٠٠ | ٩١٬٦٠٧ | |
2022-05-19 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | ٤١٬٠٠٦ | ٤١٬٠٠٦ | |||||
2022-05-19 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٨٬٩٩٤ | ٥٢٬١١٤ | ٢٠٫٨٦ | ||||
2022-04-01 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ١٣٬٠٤٣ | ٤٣٬١٢٠ | ٤٣٫٣٧ | ١٫١٥ | ١٤٬٩٩٩ | ٤٩٬٥٨٨ | |
2022-03-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٢٬٢٥٣ | ٦٦٬٠٤٧ | ٣٫٣٠ | ||||
2022-03-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٤٬٦١٢ | ٢٣٥٬٣٨٨ | ١٫٩٢ | ||||
2022-03-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٢٢٩٬٧٥٧ | ٠ | ١٠٠٫٠٠ | ||||
2022-03-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٬٢٥٣ | ١٬١٦٧٬٦٠٦ | ٠٫١٩ | ٤٤٫٣٧ | ٩٩٬٩٦٦ | ٥١٬٨٠٦٬٦٧٨ | |
2022-03-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٤٬٦١٢ | ١٬١٦٥٬٣٥٣ | ٠٫٤٠ | ٢١٫٦٨ | ٩٩٬٩٨٨ | ٢٥٬٢٦٤٬٨٥٣ | |
2022-03-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٢٩٬٧٥٧ | ١٬١٦٠٬٧٤١ | ٢٤٫٦٨ | ٥٫٧٠ | ١٬٣٠٩٬٦١٥ | ٦٬٦١٦٬٢٢٤ | |
2022-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٤٬٢٩٩ | ٩٣٠٬٩٨٤ | ١٫٥١ | ٧٦٫٦٩ | ١٬٠٩٦٬٥٩٠ | ٧١٬٣٩٧٬١٦٣ |
2022-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٩٬٣١٢ | ٩٬٣١٢ | ٥٠٫٠٠ | ||||
2022-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٥٧٥ | ٠ | ١٠٠٫٠٠ | ||||
2022-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٩٬٣١٢ | ٩٤٥٬٢٨٣ | ٠٫٩٩ | ||||
2022-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٥٧٥ | ٩٣٥٬٩٧١ | ٢٫٢٥ | ||||
2022-03-01 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ٥٢٬٧٢٢ | ٥٢٬٧٢٢ | |||||
2022-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٢٧٬١٢٦ | ٩١٥٬٣٩٦ | ٢٫٨٨ | ٧٠٫١٠ | ١٬٩٠١٬٥٣٣ | ٦٤٬١٦٩٬٢٦٠ |
2022-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Performance Stock Units |
M - Exercise | ٥٨٬٦٤٣ | ٠ | ١٠٠٫٠٠ | ||||
2022-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٥٨٬٦٤٣ | ٩٤٢٬٥٢٢ | ٦٫٦٣ | ||||
2022-02-24 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٥٬١٨٨ | ٨٨٣٬٨٧٩ | ٠٫٥٨ | ٦٩٫٠٥ | ٣٥٨٬٢٣١ | ٦١٬٠٣١٬٨٤٥ |
2022-02-24 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ١٠٬٣٧٣ | ٣١٬١٢٢ | ٢٥٫٠٠ | ||||
2022-02-24 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٠٬٣٧٣ | ٨٨٩٬٠٦٧ | ١٫١٨ | ||||
2022-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٤٬٤٠٩ | ٨٧٨٬٦٩٤ | ١٫٦١ | ٧٩٫٥٥ | ١٬١٤٦٬٢٣٦ | ٦٩٬٩٠٠٬١٠٨ |
2022-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٣١٬١٣٣ | ٦٢٬٢٦٥ | ٣٣٫٣٣ | ||||
2022-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٩٦٬٧٥٨ | ٠ | ١٠٠٫٠٠ | ||||
2022-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٩٤٬٤٢٥ | ٠ | ١٠٠٫٠٠ | ||||
2022-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣١٬١٣٣ | ٨٩٣٬١٠٣ | ٣٫٦١ | ٧٨٫٣٣ | ٢٬٤٣٨٬٦٤٨ | ٦٩٬٩٥٦٬٧٥٨ | |
2022-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٩٦٬٧٥٨ | ٨٦١٬٩٧٠ | ١٢٫٦٤ | ١٠٫٨٢ | ١٬٠٤٦٬٩٢٢ | ٩٬٣٢٦٬٥١٥ | |
2022-02-16 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٩٤٬٤٢٥ | ٧٦٥٬٢١٢ | ١٤٫٠٨ | ٩٫٠٧ | ٨٥٦٬٤٣٥ | ٦٬٩٤٠٬٤٧٣ | |
2022-01-28 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
A - Award | ١٦٬٧٢٢ | ١٦٬٧٢٢ | |||||
2022-01-28 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | ٦٬٦٨٩ | ٨٬١٩٣ | ٤٤٤٫٧٥ | ||||
2022-01-19 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٦٬٤٠٧ | ٦٧٠٬٧٨٧ | ٠٫٩٦ | ||||
2022-01-04 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٦٬٠٠٠ | ٣٠٬٠٧٧ | ٢٤٫٩٢ | ٢٫٥٠ | ١٥٬٠٠٠ | ٧٥٬١٩٢ | |
2021-11-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٦٬٩٢٢ | ٦٦٤٬٣٨٠ | ٢٫٤٨ | ٩٣٫٨٨ | ١٬٥٨٨٬٦٣٧ | ٦٢٬٣٧١٬٩٩٤ |
2021-10-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٧٬٠٧٨ | ٦٨١٬٣٠٢ | ٢٫٤٥ | ٩٣٫٦٤ | ١٬٥٩٩٬١٨٤ | ٦٣٬٧٩٧٬١١٩ |
2021-10-01 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٢٬٩٣٠ | ٢٤٬٠٧٧ | ١٣٫٨٦ | ٥٫١٢ | ١٥٬٠٠٢ | ١٢٣٬٢٧٤ | |
2021-09-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٨٬٩٧٨ | ٦٩٨٬٣٨٠ | ٢٫٦٥ | ١٠٤٫٤٢ | ١٬٩٨١٬٦٨٣ | ٧٢٬٩٢٤٬٨٤٠ |
2021-09-03 |
|
4 | SLGCW |
SomaLogic, Inc.
Class B Common Stock |
M - Exercise | ٢٥٬٠٠٠ | ٠ | ١٠٠٫٠٠ | ||||
2021-09-03 |
|
4 | SLGCW |
SomaLogic, Inc.
Warrants to purchase Class A Common Stock (right to buy) |
A - Award | ١٦٦٬٦٦٦ | ١٦٦٬٦٦٦ | |||||
2021-09-03 |
|
4 | SLGCW |
SomaLogic, Inc.
Class A Common Stock |
J - Other | ٢٥٬٠٠٠ | ٢٥٬٠٠٠ | |||||
2021-08-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٩٬٩٧٠ | ٧١٧٬٣٥٨ | ٢٫٧١ | ١٠٧٫٥٠ | ٢٬١٤٦٬٧٧٥ | ٧٧٬١١٥٬٩٨٥ |
2021-07-06 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٧٬٧٨٤ | ٧٣٧٬٣٢٨ | ١٫٠٤ | ١٢٣٫٤٣ | ٩٦٠٬٧٧٩ | ٩١٬٠٠٨٬٣٩٥ |
2021-07-01 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ١٬٨٠٥ | ٢١٬١٤٧ | ٩٫٣٣ | ٨٫٣١ | ١٥٬٠٠٠ | ١٧٥٬٧٣٢ | |
2021-06-15 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | ٤٠٬٥٥٩ | ٤٠٬٥٥٩ | |||||
2021-06-15 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٨٬٠٦٠ | ١٩٬٣٤٢ | ٧١٫٤٤ | ||||
2021-06-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٢٬٣٨٤ | ٧٤٥٬١١٢ | ١٫٦٣ | ١١١٫٠٠ | ١٬٣٧٤٬٦٢٤ | ٨٢٬٧٠٧٬٤٣٢ |
2021-05-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٩٬٢٤٠ | ٧٥٧٬٤٩٦ | ٢٫٤٨ | ١٣١٫٠٩ | ٢٬٥٢٢٬١٧٢ | ٩٩٬٣٠٠٬١٥١ |
2021-05-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٣٢٨ | ٧٧٦٬٧٣٦ | ٠٫٠٤ | ٦٤٫٧٤ | ٢١٬٢٣٥ | ٥٠٬٢٨٥٬٨٨٩ | |
2021-04-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٢٢٬٧٥٥ | ٧٧٦٬٤٠٨ | ٢٫٨٥ | ١٣٢٫٣٠ | ٣٬٠١٠٬٤٨٦ | ١٠٢٬٧١٨٬٧٧٨ |
2021-04-01 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ١٬٧٢٣ | ١١٬٢٨٢ | ١٨٫٠٢ | ٨٫٧١ | ١٥٬٠٠٧ | ٩٨٬٢٦٦ | |
2021-03-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٬٧٩٦ | ٧٩٩٬١٦٣ | ١٫٢١ | ١٣٨٫٤٢ | ١٬٣٥٥٬٩٦٢ | ١١٠٬٦٢٠٬١٤٢ |
2021-03-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٥٧٥ | ٢٠٬٥٧٥ | ٥٠٫٠٠ | ||||
2021-03-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٥٧٥ | ٨٠٨٬٩٥٩ | ٢٫٦١ | ||||
2021-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٢٦٬٩٥٨ | ٧٨٨٬٣٨٤ | ٣٫٣١ | ١٣٦٫٧٩ | ٣٬٦٨٧٬٥٨٥ | ١٠٧٬٨٤٣٬٠٤٧ |
2021-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٤٬٣٣٥ | ٨١٥٬٣٤٢ | ٠٫٥٣ | ١٣٧٫٤٤ | ٥٩٥٬٨٠٢ | ١١٢٬٠٦٠٬٦٠٤ |
2021-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٩٬٣١٢ | ١٨٬٦٢٤ | ٣٣٫٣٣ | ||||
2021-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٩٬٣١٢ | ٨١٩٬٦٧٧ | ١٫١٥ | ||||
2021-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٦٬٤٢٠ | ٨١٠٬٣٦٥ | ١٫٩٩ | ١٣٦٫٣٠ | ٢٬٢٣٨٬٠٤٦ | ١١٠٬٤٥٢٬٧٥٠ |
2021-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٣٤٬٣٢٥ | ٠ | ١٠٠٫٠٠ | ||||
2021-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣٤٬٣٢٥ | ٨٢٦٬٧٨٥ | ٤٫٣٣ | ||||
2021-02-23 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ٤١٬٤٩٥ | ٤١٬٤٩٥ | |||||
2021-02-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٥٬٨٢٥ | ٧٩٢٬٤٦٠ | ١٫٩٦ | ١٤٢٫٦٦ | ٢٬٢٥٧٬٥٩٤ | ١١٣٬٠٥٢٬٣٤٤ |
2021-02-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٣١٬١٣٢ | ٩٣٬٣٩٨ | ٢٥٫٠٠ | ||||
2021-02-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣١٬١٣٢ | ٨٠٨٬٢٨٥ | ٤٫٠١ | ||||
2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
A - Award | ٣٬٧٥٩ | ٣٬٧٥٩ | |||||
2021-02-17 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Common Stock |
A - Award | ١٬٥٠٤ | ١٬٥٠٤ | |||||
2021-02-09 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ١٧٬٥٤٣ | ٢٢٩٬٧٥٧ | ٧٫٠٩ | ||||
2021-02-09 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٧٬٥٤٣ | ٧٧٧٬١٥٣ | ٢٫٣١ | ٥٫٧٠ | ٩٩٬٩٩٥ | ٤٬٤٢٩٬٧٧٢ | |
2021-02-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٣٠٬٣٤٤ | ٧٥٩٬٦١٠ | ٣٫٨٤ | ١٣٨٫٠٧ | ٤٬١٨٩٬٥٩٦ | ١٠٤٬٨٧٩٬٣٥٣ |
2021-02-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٣٥٬٧٥٠ | ٧٨٩٬٩٥٤ | ٤٫٣٣ | ||||
2021-01-07 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٣١٬٨١٤ | ٨٢٥٬٧٠٤ | ٣٫٧١ | ١٢٨٫٧٤ | ٤٬٠٩٥٬٧٣٤ | ١٠٦٬٣٠١٬١٣٣ |
2021-01-05 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ١٬٠٢٤ | ٩٬٥٥٩ | ١٢٫٠٠ | ١٠٫٨٦ | ١١٬١٢١ | ١٠٣٬٨١١ | |
2020-12-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٠٠ | ٨٥٧٬٥١٨ | ٠٫٠١ | ١٢٦٫٥٩ | ١٢٬٦٥٩ | ١٠٨٬٥٥٣٬٢٠٤ |
2020-12-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٠٠ | ٨٥٧٬٦١٨ | ٠٫٠١ | ١٢٦٫٤٩ | ١٢٬٦٤٩ | ١٠٨٬٤٨٠٬١٠١ |
2020-12-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٧٬٠٤٣ | ٨٥٧٬٧١٨ | ٠٫٨١ | ١٢٥٫٩٢ | ٨٨٦٬٨٥٥ | ١٠٨٬٠٠٣٬٨٥١ |
2020-12-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٠٬٨٤٠ | ٨٦٤٬٧٦١ | ١٫٢٤ | ١٢٤٫٨٨ | ١٬٣٥٣٬٦٩٩ | ١٠٧٬٩٩١٬٣٥٤ |
2020-12-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٧٬٧٧٦ | ٨٧٥٬٦٠١ | ٠٫٨٨ | ١٢٤٫٠٣ | ٩٦٤٬٤٥٧ | ١٠٨٬٦٠٠٬٧٩٢ |
2020-12-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٢٬٩١٨ | ٨٨٣٬٣٧٧ | ٠٫٣٣ | ١٢٢٫٩١ | ٣٥٨٬٦٥١ | ١٠٨٬٥٧٥٬٨٦٧ |
2020-12-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٬٨٠٠ | ٨٨٦٬٢٩٥ | ٠٫٢٠ | ١٢٢٫٠٥ | ٢١٩٬٦٩٠ | ١٠٨٬١٧٢٬٣٠٥ |
2020-11-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٤٠٠ | ٨٨٨٬٠٩٥ | ٠٫٠٥ | ١٢٤٫٧١ | ٤٩٬٨٨٤ | ١١٠٬٧٥٤٬٣٢٧ |
2020-11-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٦٠٠ | ٨٨٨٬٤٩٥ | ٠٫٠٧ | ١٢٣٫٤٥ | ٧٤٬٠٧٠ | ١٠٩٬٦٨٤٬٧٠٨ |
2020-11-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٬٥٧٧ | ٨٨٩٬٠٩٥ | ١٫٠٧ | ١٢٢٫٣٣ | ١٬١٧١٬٥٥٤ | ١٠٨٬٧٦٢٬٩٩١ |
2020-11-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٠٬٢٢٩ | ٨٩٨٬٦٧٢ | ١٫١٣ | ١٢١٫٥٢ | ١٬٢٤٣٬٠٢٨ | ١٠٩٬٢٠٦٬٦٢١ |
2020-11-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٦٬٥١٢ | ٩٠٨٬٩٠١ | ٠٫٧١ | ١٢٠٫٤٥ | ٧٨٤٬٣٧٠ | ١٠٩٬٤٧٧٬١٢٥ |
2020-11-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٬١٠٨ | ٩١٥٬٤١٣ | ٠٫١٢ | ١١٩٫١٨ | ١٣٢٬٠٥١ | ١٠٩٬٠٩٨٬٩٢١ |
2020-11-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٤٬٣٩٣ | ٩١٦٬٥٢١ | ٠٫٤٨ | ١١٨٫٣٢ | ٥١٩٬٧٨٠ | ١٠٨٬٤٤٢٬٧٦٥ |
2020-10-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٬١٣٦ | ٩٢٠٬٩١٤ | ٠٫١٢ | ١٠٥٫٢٠ | ١١٩٬٥٠٧ | ٩٦٬٨٨٠٬١٥٣ |
2020-10-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٥٬٢٠٠ | ٩٢٢٬٠٥٠ | ٠٫٥٦ | ١٠٤٫٧٠ | ٥٤٤٬٤٤٠ | ٩٦٬٥٣٨٬٦٣٥ |
2020-10-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٬٣٩١ | ٩٢٧٬٢٥٠ | ١٫٠٠ | ١٠٣٫٥٧ | ٩٧٢٬٦٢٦ | ٩٦٬٠٣٥٬٢٨٢ |
2020-10-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١١٬٦٩٨ | ٩٣٦٬٦٤١ | ١٫٢٣ | ١٠٢٫٨٦ | ١٬٢٠٣٬٢٥٦ | ٩٦٬٣٤٢٬٨٩٣ |
2020-10-01 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٩٣٣ | ٨٬٥٣٥ | ١٢٫٢٧ | ١١٫٩٣ | ١١٬١٣١ | ١٠١٬٨٢٣ | |
2020-09-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٩٬٩٢٧ | ٩٤٨٬٣٣٩ | ٢٫٠٦ | ٧٥٫٠٣ | ١٬٤٩٥٬١٢٣ | ٧١٬١٥٣٬٨٧٥ |
2020-08-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٩٨ | ٩٦٨٬٢٦٦ | ٠٫٠٢ | ٩٥٫٠٠ | ١٨٬٨١٠ | ٩١٬٩٨٥٬٢٧٠ |
2020-08-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٢٥٬٠٠٠ | ٩٦٨٬٤٦٤ | ٢٫٥٢ | ٩٣٫٧٩ | ٢٬٣٤٤٬٧٥٠ | ٩٠٬٨٣٢٬٢٣٩ |
2020-08-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٥٠١ | ٩٩٣٬٤٦٤ | ٠٫٠٥ | ٤٢٫٤٤ | ٢١٬٢٦٢ | ٤٢٬١٦٢٬٦١٢ | |
2020-07-06 |
|
4 | ARYA |
ARYA SCIENCES ACQUISITION CORP.
Class B Ordinary Shares |
D - Sale to Issuer | ٣٠٬٠٠٠ | ٠ | ١٠٠٫٠٠ | ||||
2020-07-01 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٦٩٣ | ٧٬٦٠٢ | ١٠٫٠٣ | ١٦٫٠٦ | ١١٬١٣٠ | ١٢٢٬٠٨٨ | |
2020-06-02 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | ١٤٬٠١٣ | ١٤٬٠١٣ | |||||
2020-04-02 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٧١٧ | ٦٬٩٠٩ | ١١٫٥٨ | ١٥٫٥١ | ١١٬١٢١ | ١٠٧٬١٥٩ | |
2020-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٬٧٥٠ | ٩٩٢٬٩٦٣ | ٠٫٩٧ | ٨٠٫١٧ | ٧٨١٬٦٥٨ | ٧٩٬٦٠٥٬٨٤٤ |
2020-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٥٧٥ | ٤١٬١٥٠ | ٣٣٫٣٣ | ||||
2020-03-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٥٧٥ | ١٬٠٠٢٬٧١٣ | ٢٫٠٩ | ||||
2020-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٣٬٨٧٥ | ٩٨٢٬١٣٨ | ١٫٣٩ | ٨٠٫٢٧ | ١٬١١٣٬٧٤٦ | ٧٨٬٨٣٦٬٢١٧ |
2020-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٩٬٣١٢ | ٢٧٬٩٣٦ | ٢٥٫٠٠ | ||||
2020-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٠٢٥ | ٠ | ١٠٠٫٠٠ | ||||
2020-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٩٬٣١٢ | ٩٩٦٬٠١٣ | ٠٫٩٤ | ||||
2020-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٠٢٥ | ٩٨٦٬٧٠١ | ٢٫٠٧ | ||||
2020-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٨٬١١٥ | ٩٦٦٬٦٧٦ | ١٫٨٤ | ٨٥٫١١ | ١٬٥٤١٬٧٦٨ | ٨٢٬٢٧٣٬٧٩٤ |
2020-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٣٤٬٣٢٥ | ٣٤٬٣٢٥ | ٥٠٫٠٠ | ||||
2020-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣٤٬٣٢٥ | ٩٨٤٬٧٩١ | ٣٫٦١ | ||||
2020-02-18 |
|
4 | ADPT |
Adaptive Biotechnologies Corp
Stock Option (Right to Buy) |
A - Award | ٨٬٨٨٨ | ٨٬٨٨٨ | |||||
2020-02-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ١٢٤٬٥٣٠ | ١٢٤٬٥٣٠ | |||||
2020-02-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
A - Award | ١٠٠٬٩١٦ | ١٠٠٬٩١٦ | |||||
2020-02-14 |
|
5 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٢١٬٧٢٩ | ٢١٬٧٢٩ | |||||
2020-02-14 |
|
5 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٢١٬٧٣٠ | ٢١٬٧٣٠ | |||||
2020-02-14 |
|
5 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٢١٬٧٣٠ | ٢١٬٧٣٠ | |||||
2020-02-14 |
|
5 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٦٥٬١٨٩ | ٠ | ١٠٠٫٠٠ | ||||
2020-01-03 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٤٥٢ | ٦٬١٩٢ | ٧٫٨٧ | ٢٤٫٦٠ | ١١٬١١٩ | ١٥٢٬٣٢٣ | |
2019-12-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٤٬٢٧٧ | ٦٦٬٧٢٣ | ٦٫٠٢ | ||||
2019-12-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٧٬١٦٣ | ١٠٢٬٨٣٧ | ٦٫٥١ | ||||
2019-12-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٤٬٢٧٧ | ٩٥٠٬٤٦٦ | ٠٫٤٥ | ٢٣٫٣٨ | ٩٩٬٩٩٦ | ٢٢٬٢٢١٬٨٩٥ | |
2019-12-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٧٬١٦٣ | ٩٤٦٬١٨٩ | ٠٫٧٦ | ١٣٫٩٦ | ٩٩٬٩٩٥ | ١٣٬٢٠٨٬٧٩٨ | |
2019-12-18 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٥٠٠ | ٩٣٩٬٠٢٦ | ٠٫٠٥ | ٤٢٫٤٤ | ٢١٬٢٢٠ | ٣٩٬٨٥٢٬٢٦٣ | |
2019-10-02 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ١٬٠٧٨ | ٥٬٧٤٠ | ٢٣٫١٢ | ١٠٫٣٢ | ١١٬١٢٥ | ٥٩٬٢٣٧ | |
2019-07-02 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٨٨٧ | ٤٬٦٦٢ | ٢٣٫٥٠ | ١٢٫٥٥ | ١١٬١٣٢ | ٥٨٬٥٠٨ | |
2019-06-07 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | ١٧٬٦٣٣ | ١٧٬٦٣٣ | |||||
2019-06-07 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٨٩٧ | ٣٬٧٧٥ | ٣١٫١٧ | ١٢٫٣٩ | ١١٬١١٤ | ٤٦٬٧٧٢ | |
2019-03-12 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١١٬٢٢٧ | ٩٣٨٬٥٢٦ | ١٫١٨ | ٨٧٫٢١ | ٩٧٩٬١٢٩ | ٨١٬٨٥٠٬٧٣٠ |
2019-03-12 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٤٬٤٠٠ | ٠ | ١٠٠٫٠٠ | ||||
2019-03-12 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٤٬٤٠٠ | ٩٤٩٬٧٥٣ | ٢٫٦٤ | ||||
2019-03-01 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٠٬٠١٤ | ٩٢٥٬٣٥٣ | ١٫٠٧ | ٩٣٫٢٠ | ٩٣٣٬٣٤٥ | ٨٦٬٢٤٦٬٦٠١ |
2019-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٥٧٥ | ٦١٬٧٢٥ | ٢٥٫٠٠ | ||||
2019-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٥٧٥ | ٩٣٥٬٣٦٧ | ٢٫٢٥ | ||||
2019-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٬١٦٩ | ٩١٤٬٧٩٢ | ٠٫٩٩ | ٩٥٫٠٧ | ٨٧١٬٧٣٤ | ٨٦٬٩٧٢٬٩٣٥ |
2019-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ٣٧٬٢٤٨ | ٣٧٬٢٤٨ | |||||
2019-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
A - Award | ٣٤٬١١٠ | ٣٤٬١١٠ | |||||
2019-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٠٢٥ | ٢٠٬٠٢٥ | ٥٠٫٠٠ | ||||
2019-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٠٢٥ | ٩٢٣٬٩٦١ | ٢٫٢٢ | ||||
2019-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٦٬٤٠٠ | ٩٠٣٬٩٣٦ | ١٫٧٨ | ٩٠٫٥٥ | ١٬٤٨٥٬٠٣٦ | ٨١٬٨٥٢٬٣٠٩ |
2019-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٣٤٬٣٢٥ | ٦٨٬٦٥٠ | ٣٣٫٣٣ | ||||
2019-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣٤٬٣٢٥ | ٩٢٠٬٣٣٦ | ٣٫٨٧ | ||||
2019-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٢٣٬٢٣٦ | ٨٨٦٬٠١١ | ٢٫٥٦ | ٨٢٫٤٩ | ١٬٩١٦٬٦٦٨ | ٧٣٬٠٨٤٬٣٨٩ |
2019-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٨١٬٢٥٠ | ٩٠٩٬٢٤٧ | ١٦٫٦٢ | ٨١٫٩٠ | ١٤٬٨٤٤٬١٩٤ | ٧٤٬٤٦٦٬٤٢٠ |
2019-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٣٦٬٤٥٣ | ١٬٠٩٠٬٤٩٧ | ٣٫٢٣ | ٨٠٫٧٨ | ٢٬٩٤٤٬٧٨٣ | ٨٨٬٠٩٣٬٦١٩ |
2019-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٢٨٬٦٠٥ | ١٬١٢٦٬٩٥٠ | ٢٫٤٨ | ٧٩٫٨٩ | ٢٬٢٨٥٬٣٣٩ | ٩٠٬٠٣٥٬٤١٦ |
2019-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٣٤٬٨٥٣ | ١٬١٥٥٬٥٥٥ | ٢٫٩٣ | ٧٨٫٨٠ | ٢٬٧٤٦٬٤١٦ | ٩١٬٠٥٧٬٧٣٤ |
2019-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Performance Share Units |
M - Exercise | ٣٠٤٬٣٩٧ | ٠ | ١٠٠٫٠٠ | ||||
2019-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣٠٤٬٣٩٧ | ١٬١٩٠٬٤٠٨ | ٣٤٫٣٦ | ||||
2019-01-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Performance Share Units |
A - Award | ٣٠٤٬٣٩٧ | ٣٠٤٬٣٩٧ | |||||
2018-11-14 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ١٦٣٬٥١٤ | ٠ | ١٠٠٫٠٠ | ||||
2018-11-14 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٦٣٬٥١٤ | ٨٨٦٬٠١١ | ١٥٫٥٨ | ٦٩٫٠٠ | ١١٬٢٨٢٬٤٦٦ | ٦١٬١٣٤٬٧٥٩ |
2018-11-14 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٦٣٬٥١٤ | ١٬٠٤٩٬٥٢٥ | ١٨٫٤٦ | ٠٫٨٣ | ١٣٥٬٧١٧ | ٨٧١٬١٠٦ | |
2018-11-14 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٣٬٥٧٢ | ٨٨٦٬٠١١ | ٠٫٤٠ | ٥٫٩٥ | ٢١٬٢٥٣ | ٥٬٢٧١٬٧٦٥ | |
2018-07-02 |
|
4 | EPZM |
Epizyme, Inc.
Common Stock, par value $0.0001 |
A - Award | ٢٬٨٧٨ | ٢٬٨٧٨ | ١٣٫٥٥ | ٣٨٬٩٩٧ | ٣٨٬٩٩٧ | ||
2018-05-31 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | ١٢٬٥٠٠ | ١٢٬٥٠٠ | |||||
2018-03-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١١٬٤٥٩ | ٨٨٢٬٤٣٩ | ١٫٢٨ | ٥٢٫١٩ | ٥٩٨٬٠٩١ | ٤٦٬٠٥٨٬٠٢١ |
2018-03-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٤٬٤٠٠ | ٢٤٬٤٠٠ | ٥٠٫٠٠ | ||||
2018-03-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٤٬٤٠٠ | ٨٩٣٬٨٩٨ | ٢٫٨١ | ||||
2018-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ٨٢٬٣٠٠ | ٨٢٬٣٠٠ | |||||
2018-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
A - Award | ٦٨٬٣٠٠ | ٦٨٬٣٠٠ | |||||
2018-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٬٠٨٥ | ٨٦٩٬٤٩٨ | ١٫٠٣ | ٤٤٫١٠ | ٤٠٠٬٦٣٠ | ٣٨٬٣٤٣٬١٢٣ |
2018-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٠٢٥ | ٤٠٬٠٥٠ | ٣٣٫٣٣ | ||||
2018-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٠٢٥ | ٨٧٨٬٥٨٣ | ٢٫٣٣ | ||||
2018-02-27 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٢٥٬٣١٩ | ٨٥٨٬٥٥٨ | ٢٫٨٦ | ٤٢٫٣٤ | ١٬٠٧١٬٩٥٦ | ٣٦٬٣٤٩٬٦٢٩ |
2018-02-27 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ١٩٬٥٠٠ | ٠ | ١٠٠٫٠٠ | ||||
2018-02-27 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٩٬٥٠٠ | ٨٨٣٬٨٧٧ | ٢٫٢٦ | ||||
2018-02-27 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٣٤٬٣٢٥ | ١٠٢٬٩٧٥ | ٢٥٫٠٠ | ||||
2018-02-27 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣٤٬٣٢٥ | ٨٦٤٬٣٧٧ | ٤٫١٤ | ||||
2018-02-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ١٠١٬٤٨٨ | ١٦٣٬٥١٤ | ٣٨٫٣٠ | ||||
2018-02-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٩٬٤٥٨ | ٨٣٠٬٠٥٢ | ١٫١٣ | ٤٦٫٢٩ | ٤٣٧٬٨٣٩ | ٣٨٬٤٢٥٬٥٩٧ | |
2018-02-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٥٠٬٥٠٤ | ٨٣٩٬٥١٠ | ٥٫٦٧ | ٤٦٫٥٤ | ٢٬٣٥٠٬٤٥٦ | ٣٩٬٠٧٠٬٧٩٥ | |
2018-02-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٤١٬٥٢٦ | ٨٩٠٬٠١٤ | ٤٫٤٦ | ٤٤٫٦٠ | ١٬٨٥١٬٩٧٧ | ٣٩٬٦٩٢٬٨٤٤ | |
2018-02-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | X | ١٠١٬٤٨٨ | ٩٣١٬٥٤٠ | ١٢٫٢٣ | ٠٫٨٣ | ٨٤٬٢٣٥ | ٧٧٣٬١٧٨ |
2018-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ١١٠٬٤٣٩ | ٢٦٥٬٠٠٢ | ٢٩٫٤٢ | ||||
2018-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٣٠٬٠٣٦ | ٨٣٠٬٠٥٢ | ٣٫٤٩ | ٥١٫٦٦ | ١٬٥٥١٬٦٦٠ | ٤٢٬٨٨٠٬٤٨٦ | |
2018-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٤١٬٥٨٨ | ٨٦٠٬٠٨٨ | ٤٫٦١ | ٥٠٫٧٢ | ٢٬١٠٩٬٤٢٧ | ٤٣٬٦٢٥٬٣٨٤ | |
2018-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٢٦٬٧٣٨ | ٩٠١٬٦٧٦ | ٢٫٨٨ | ٤٩٫٥٤ | ١٬٣٢٤٬٧٠٧ | ٤٤٬٦٧٢٬٦٣٦ | |
2018-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ١٢٬٠٧٧ | ٩٢٨٬٤١٤ | ١٫٢٨ | ٤٨٫٨٧ | ٥٩٠٬١٦٧ | ٤٥٬٣٦٨٬٨٠٧ | |
2018-01-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | X | ١١٠٬٤٣٩ | ٩٤٠٬٤٩١ | ١٣٫٣١ | ٠٫٨٣ | ٩١٬٦٦٤ | ٧٨٠٬٦٠٨ |
2018-01-17 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ١٢٥٬٤٠٢ | ٣٧٥٬٤٤١ | ٢٥٫٠٤ | ||||
2018-01-17 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٢٥٬٩١٢ | ٨٣٠٬٠٥٢ | ٣٫٠٣ | ٥٣٫٢٤ | ١٬٣٧٩٬٦٥٩ | ٤٤٬١٩٥٬٢٨٩ | |
2018-01-17 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٩٩٬٤٩٠ | ٨٥٥٬٩٦٤ | ١٠٫٤١ | ٥٢٫٦٨ | ٥٬٢٤٠٬٩٣٤ | ٤٥٬٠٩٠٬٤٧٢ | |
2018-01-17 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | X | ١٢٥٬٤٠٢ | ٩٥٥٬٤٥٤ | ١٥٫١١ | ٠٫٨٣ | ١٠٤٬٠٨٤ | ٧٩٣٬٠٢٧ |
2017-12-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ١٢٣٬٥١٢ | ٥٠٠٬٨٤٣ | ١٩٫٧٨ | ||||
2017-12-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٢٧٬٠٦٥ | ٨٣٠٬٠٥٢ | ٣٫١٦ | ٥٣٫٣٦ | ١٬٤٤٤٬٠٥٣ | ٤٤٬٢٨٧٬٤٢٤ |
2017-12-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٦٬٤٤٧ | ٨٥٧٬١١٧ | ١٠٫١١ | ٥٢٫٣٧ | ٥٬٠٥٠٬٧٣٦ | ٤٤٬٨٨٥٬٥٠٣ |
2017-12-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٢٣٬٥١٢ | ٩٥٣٬٥٦٤ | ١٤٫٨٨ | ٠٫٨٣ | ١٠٢٬٥١٥ | ٧٩١٬٤٥٨ | |
2017-12-08 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ١٢١٬٨٤٩ | ٦٢٤٬٣٥٥ | ١٦٫٣٣ | ||||
2017-12-08 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٢٨٬٣٧٠ | ٨٣٠٬٠٥٢ | ٣٫٣٠ | ٥٣٫٨٠ | ١٬٥٢٦٬٤٤٨ | ٤٤٬٦٦٠٬٩٤٨ |
2017-12-08 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٣٬٤٧٩ | ٨٥٨٬٤٢٢ | ٩٫٨٢ | ٥٣٫٣٥ | ٤٬٩٨٦٬٧٣١ | ٤٥٬٧٩٣٬٣٨٠ |
2017-12-08 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٢١٬٨٤٩ | ٩٥١٬٩٠١ | ١٤٫٦٨ | ٠٫٨٣ | ١٠١٬١٣٥ | ٧٩٠٬٠٧٨ | |
2017-11-22 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ١٣٤٬٠٥٧ | ٧٤٦٬٢٠٤ | ١٥٫٢٣ | ||||
2017-11-22 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٣٤٬٠٥٧ | ٨٣٠٬٠٥٢ | ١٣٫٩٠ | ٥٩٫٥٠ | ٧٬٩٧٦٬٦٦٠ | ٤٩٬٣٨٩٬٧٥٤ |
2017-11-22 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٣٤٬٠٥٧ | ٩٦٤٬١٠٩ | ١٦٫١٥ | ٠٫٨٣ | ١١١٬٢٦٧ | ٨٠٠٬٢١٠ | |
2017-11-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ١٣٧٬٨١٥ | ٨٨٠٬٢٦١ | ١٣٫٥٤ | ||||
2017-11-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٥٬٤٢٤ | ٨٣٠٬٠٥٢ | ٠٫٦٥ | ٦٠٫٠٥ | ٣٢٥٬٦٩٠ | ٤٩٬٨٤١٬٣٠٢ |
2017-11-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٨٠٬٤٠٥ | ٨٣٥٬٤٨٦ | ٨٫٧٨ | ٥٩٫٤٣ | ٤٬٧٧٨٬٥٥٠ | ٤٩٬٦٥٣٬٧٦٨ |
2017-11-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٥١٬٩٧٦ | ٩١٥٬٨٩١ | ٥٫٣٧ | ٥٨٫٥٩ | ٣٬٠٤٥٬٤٣٠ | ٥٣٬٦٦٤٬٨٠١ |
2017-11-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٣٧٬٨١٥ | ٩٦٧٬٨٦٧ | ١٦٫٦٠ | ٠٫٨٣ | ١١٤٬٣٨٦ | ٨٠٣٬٣٣٠ | |
2017-08-17 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٩٬٢٤٢ | ٩٦٬٧٥٨ | ٨٫٧٢ | ||||
2017-08-17 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٩٬٢٤٢ | ٨٣٠٬٠٥٢ | ١٫١٣ | ١٠٫٨٢ | ٩٩٬٩٩٨ | ٨٬٩٨١٬١٦٣ | |
2017-07-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ١٣٧٬٣٠٠ | ١٣٧٬٣٠٠ | |||||
2017-07-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
A - Award | ٢٤٠٬٠٠٠ | ٢٤٠٬٠٠٠ | |||||
2017-07-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٣٬٥٧١ | ٨٢٠٬٨١٠ | ٠٫٤٤ | ٥٫٩٥ | ٢١٬٢٤٧ | ٤٬٨٨٣٬٨٢٠ | |
2017-03-14 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٢٬٠٥٩ | ٨١٧٬٢٣٩ | ١٫٤٥ | ٢١٫١٦ | ٢٥٥٬١٦٨ | ١٧٬٢٩٢٬٧٧٧ |
2017-03-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٤٬٤٠٠ | ٤٨٬٨٠٠ | ٣٣٫٣٣ | ||||
2017-03-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٤٬٤٠٠ | ٨٢٩٬٢٩٨ | ٣٫٠٣ | ||||
2017-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٩٬٥٥٧ | ٨٠٤٬٨٩٨ | ٢٫٣٧ | ٢١٫٤٨ | ٤٢٠٬٠٨٤ | ١٧٬٢٨٩٬٢٠٩ |
2017-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٠٢٥ | ٦٠٬٠٧٥ | ٢٥٫٠٠ | ||||
2017-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٠٢٥ | ٨٢٤٬٤٥٥ | ٢٫٤٩ | ||||
2017-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ١٩٬٥٠٠ | ١٩٬٥٠٠ | ٥٠٫٠٠ | ||||
2017-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٩٬٥٠٠ | ٨٠٤٬٤٣٠ | ٢٫٤٨ | ||||
2017-02-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٧٬٥٧٧ | ٧٨٤٬٩٣٠ | ٠٫٩٦ | ٢١٫٥٧ | ١٦٣٬٤٣٦ | ١٦٬٩٣٠٬٩٤٠ |
2017-02-24 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ١٩٬٣٧٥ | ٠ | ١٠٠٫٠٠ | ||||
2017-02-24 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٩٬٣٧٥ | ٧٩٢٬٥٠٧ | ٢٫٥١ | ||||
2017-02-07 |
|
4 | EPZM |
Epizyme, Inc.
Stock Option (Right to Buy) |
A - Award | ٢٥٬٠٠٠ | ٢٥٬٠٠٠ | |||||
2016-11-15 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٣٣٬٠٧٥ | ٩٤٬٤٢٥ | ٢٥٫٩٤ | ||||
2016-11-15 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣٣٬٠٧٥ | ٧٧٣٬١٣٢ | ٤٫٤٧ | ٩٫٠٧ | ٢٩٩٬٩٩٠ | ٧٬٠١٢٬٣٠٧ | |
2016-11-15 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٢٧٥٬٠٠٠ | ٧٤٠٬٠٥٧ | ٢٧٫٠٩ | ١٧٫٣٦ | ٤٬٧٧٤٬٠٠٠ | ١٢٬٨٤٧٬٣٩٠ | |
2016-11-15 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٢٧٥٬٠٠٠ | ١٬٠١٥٬٠٥٧ | ٢١٫٣٢ | ١٧٫٥٢ | ٤٬٨١٨٬٠٠٠ | ١٧٬٧٨٣٬٧٩٩ | |
2016-11-15 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٦٠٠٬٠٠٠ | ١٬٠١٨٬٠٧٦ | ٣٧٫٠٨ | ||||
2016-11-15 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | ٥٠٬٠٠٠ | ١٬٢٩٠٬٠٥٧ | ٣٫٧٣ | ١٧٫٦٨ | ٨٨٤٬٠٠٠ | ٢٢٬٨٠٨٬٢٠٨ | |
2016-11-15 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٦٠٠٬٠٠٠ | ١٬٣٤٠٬٠٥٧ | ٨١٫٠٧ | ٠٫٨٣ | ٤٩٨٬٠٠٠ | ١٬١١٢٬٢٤٧ | |
2016-07-27 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٥٬٠٠٠ | ٠ | ١٠٠٫٠٠ | ||||
2016-07-27 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٥٬٠٠٠ | ٧٤٠٬٠٥٧ | ٣٫٥٠ | ||||
2016-07-27 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٢٬٧٥٠ | ٧١٥٬٠٥٧ | ٠٫٣٩ | ٥٫٩٥ | ١٦٬٣٦٢ | ٤٬٢٥٤٬٥٨٩ | |
2016-03-11 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٤٬٤٠٠ | ٧٣٬٢٠٠ | ٢٥٫٠٠ | ||||
2016-03-11 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٤٬٤٠٠ | ٧١٢٬٣٠٧ | ٣٫٥٥ | ||||
2016-03-11 |
|
4/A | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ٨٠٬١٠٠ | ٨٠٬١٠٠ | |||||
2016-03-11 |
|
4/A | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
A - Award | ٢٤٧٬٣٠٠ | ٢٤٧٬٣٠٠ | |||||
2016-03-11 |
|
4/A | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٦٬٨٩٥ | ٦٣٧٬٩٠٧ | ١٫٠٧ | ٥٫٨١ | ٤٠٬٠٦٠ | ٣٬٧٠٦٬٢٤٠ |
2016-03-01 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
P - Purchase | X | ٥٠٬٠٠٠ | ٦٨٧٬٩٠٧ | ٧٫٨٤ | ٥٫٠٠ | ٢٥٠٬٠٠٠ | ٣٬٤٣٩٬٥٣٥ |
2016-02-29 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٦٬٨٩٥ | ٦٣٧٬٩٠٧ | ١٫٠٧ | ٥٫٨١ | ٤٠٬٠٦٠ | ٣٬٧٠٦٬٢٤٠ |
2016-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ١٩٬٥٠٠ | ٣٩٬٠٠٠ | ٣٣٫٣٣ | ||||
2016-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٩٬٥٠٠ | ٦٤٤٬٨٠٢ | ٣٫١٢ | ||||
2016-02-24 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٦٬٨٦٦ | ٦٢٥٬٣٠٢ | ١٫٠٩ | ٦٫٣٩ | ٤٣٬٨٧٤ | ٣٬٩٩٥٬٦٨٠ |
2016-02-24 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ١٩٬٣٧٥ | ١٩٬٣٧٥ | ٥٠٫٠٠ | ||||
2016-02-24 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٩٬٣٧٥ | ٦٣٢٬١٦٨ | ٣٫١٦ | ||||
2016-01-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٢٦٥٬٩٢٤ | ١٬٦١٨٬٠٧٦ | ١٤٫١١ | ||||
2016-01-13 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٦٥٬٩٢٤ | ٦١٢٬٩٧٣ | ٧٦٫٦٢ | ٠٫٨٣ | ٢٢٠٬٧١٧ | ٥٠٨٬٧٦٨ | |
2016-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٠٬٧٥٠ | ٣٤٦٬٨٦٩ | ٣٫٠١ | ٨٫٧٢ | ٩٣٬٧٤٠ | ٣٬٠٢٤٬٦٩٨ |
2016-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٤٦٦ | ٠ | ١٠٠٫٠٠ | ||||
2016-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٤٦٦ | ٣٥٧٬٦١٩ | ٦٫٠٧ | ||||
2016-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٧٨٧ | ٣٣٧٬١٥٣ | ٠٫٢٣ | ||||
2016-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٣٤٠ | ٣٣٧٬٩٤٠ | ٠٫١٠ | ||||
2016-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ١٬٠٠٠ | ٣٣٨٬٢٨٠ | ٠٫٢٩ | ||||
2016-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٣٩٥ | ٣٣٩٬٢٨٠ | ٠٫١٢ | ||||
2015-12-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ٨١٬٠٠٠ | ١٬٨٨٤٬٠٠٠ | ٤٫١٢ | ||||
2015-12-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٨١٬٠٠٠ | ٣٣٨٬٣٣٥ | ٣١٫٤٨ | ٠٫٨٣ | ٦٧٬٢٣٠ | ٢٨٠٬٨١٨ | |
2015-07-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١١٬٣٨٦ | ٢٥٧٬٣٣٥ | ٤٫٢٤ | ٢٤٫٠٤ | ٢٧٣٬٧١٩ | ٦٬١٨٦٬٣٣٣ |
2015-07-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٥٬٠٠٠ | ٢٥٬٠٠٠ | ٥٠٫٠٠ | ||||
2015-07-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٥٬٠٠٠ | ٢٦٨٬٧٢١ | ١٠٫٢٦ | ||||
2015-07-28 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ١٬١٩٥ | ٢٤٤٬٠٦١ | ٠٫٤٩ | ١٧٫٧٨ | ٢١٬٢٤٧ | ٤٬٣٣٩٬٤٠٥ | |
2015-03-11 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ٩٧٬٦٠٠ | ٩٧٬٦٠٠ | |||||
2015-03-11 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
A - Award | ٧١٬٠٠٠ | ٧١٬٠٠٠ | |||||
2015-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٨٬٤٢٥ | ٢٤٣٬٨٦٦ | ٣٫٣٤ | ٢٣٫٤٤ | ١٩٧٬٤٨٢ | ٥٬٧١٦٬٢١٩ |
2015-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ١٩٬٥٠٠ | ٥٨٬٥٠٠ | ٢٥٫٠٠ | ||||
2015-02-26 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٩٬٥٠٠ | ٢٥٢٬٢٩١ | ٨٫٣٨ | ||||
2015-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٬٧٩٨ | ٢٣٢٬٧٩١ | ٤٫٠٤ | ٢٢٫٩٠ | ٢٢٤٬٣٧٤ | ٥٬٣٣٠٬٩١٤ |
2015-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ١٩٬٣٧٥ | ٣٨٬٧٥٠ | ٣٣٫٣٣ | ||||
2015-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٩٬٣٧٥ | ٢٤٢٬٥٨٩ | ٨٫٦٨ | ||||
2015-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٬٤٨٤ | ٢٢٣٬٢١٤ | ٤٫٠٨ | ٢٦٫٧٢ | ٢٥٣٬٤١٢ | ٥٬٩٦٤٬٢٧٨ |
2015-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٤٦٧ | ٢٠٬٤٦٦ | ٥٠٫٠٠ | ||||
2015-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٤٦٧ | ٢٣٢٬٦٩٨ | ٩٫٦٤ | ||||
2015-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ١٬٠٢٥ | ٢١٢٬٢٣١ | ٠٫٤٨ | ||||
2015-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٥٨٣ | ٢١٣٬٢٥٦ | ٠٫٢٧ | ||||
2015-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٦٥٬١٨٩ | ٦٥٬١٨٩ | |||||
2015-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٦٥٬١٨٩ | ٢١٣٬٨٣٩ | ٢٣٫٣٦ | ||||
2015-01-05 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ١٬٥٣٥ | ٢٧٩٬٠٢٨ | ٠٫٥٥ | ||||
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | ١٣٥٬٠٠٠ | ١٬٩٦٥٬٠٠٠ | ٦٫٤٣ | ||||
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | X | ١٣٣٬٣٣٤ | ٢٬١٠٠٬٠٠٠ | ٥٫٩٧ | |||
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٣٥٬٠٠٠ | ٢٨٠٬٥٦٣ | ٩٢٫٧٤ | ٠٫٨٣ | ١١٢٬٠٥٠ | ٢٣٢٬٨٦٧ | |
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٣٣٬٣٣٤ | ١٤٥٬٥٦٣ | ٤٧٫٨١ | ٢٣٫٩٣ | ٣٬١٩٠٬٩٨٩ | ٣٬٤٨٣٬٦٥٧ |
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | X | ١٣٣٬٣٣٤ | ٢٧٨٬٨٩٧ | ٩١٫٦٠ | ٠٫٨٣ | ١١٠٬٦٦٧ | ٢٣١٬٤٨٥ |
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | X | ١٣٣٬٣٣٣ | ٢٬٢٣٣٬٣٣٤ | ٥٫٦٣ | |||
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٣٣٬٣٣٣ | ١٤٥٬٥٦٣ | ٤٧٫٨١ | ٢٣٫٦٨ | ٣٬١٥٧٬٦٣٢ | ٣٬٤٤٧٬٢٦٧ |
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | X | ١٣٣٬٣٣٣ | ٢٧٨٬٨٩٦ | ٩١٫٦٠ | ٠٫٨٣ | ١١٠٬٦٦٦ | ٢٣١٬٤٨٤ |
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
M - Exercise | X | ١٣٣٬٣٣٣ | ٢٬٣٦٦٬٦٦٧ | ٥٫٣٣ | |||
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٣٣٬٣٣٣ | ١٤٥٬٥٦٣ | ٤٧٫٨١ | ٢٢٫٨٤ | ٣٬٠٤٥٬٥٦٦ | ٣٬٣٢٤٬٩٢١ |
2014-10-20 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | X | ١٣٣٬٣٣٣ | ٢٧٨٬٨٩٦ | ٩١٫٦٠ | ٠٫٨٣ | ١١٠٬٦٦٦ | ٢٣١٬٤٨٤ |
2014-07-29 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٥٬٠٠٠ | ٥٠٬٠٠٠ | ٣٣٫٣٣ | ||||
2014-07-29 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١١٬٣٣٦ | ١٤٥٬٥٦٣ | ٧٫٢٣ | ١٥٫٩٩ | ١٨١٬٢٦٣ | ٢٬٣٢٧٬٥٥٢ |
2014-07-29 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٥٬٠٠٠ | ١٥٦٬٨٩٩ | ١٨٫٩٥ | ||||
2014-07-29 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٢٬٧٢١ | ١٣١٬٨٩٩ | ٢٫١١ | ٧٫٨١ | ٢١٬٢٥١ | ١٬٠٣٠٬١٣١ | |
2014-06-20 |
|
5 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٤٬٠٩٢ | ١١٨٬٥١١ | ٣٫٣٤ | ||||
2014-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ٧٨٬٠٠٠ | ٧٨٬٠٠٠ | |||||
2014-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
A - Award | ١١٠٬٠٠٠ | ١١٠٬٠٠٠ | |||||
2014-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٨٬٧٠٨ | ١٣٤٬٣٧٤ | ٦٫٠٩ | ١٤٫٠٧ | ١٢٢٬٥٢٢ | ١٬٨٩٠٬٦٤٢ |
2014-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ١٩٬٣٧٥ | ١٤٣٬٠٨٢ | ١٥٫٦٦ | ||||
2014-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ٩٬٢٧١ | ١٢٣٬٧٠٧ | ٦٫٩٧ | ١١٫٩٦ | ١١٠٬٨٨١ | ١٬٤٧٩٬٥٣٦ |
2014-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
S - Sale | X | ١٧٬١٠٨ | ١١٢٬٥١١ | ١٣٫٢٠ | ١١٫٩٦ | ٢٠٤٬٦١٢ | ١٬٣٤٥٬٦٣٢ |
2014-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٢٠٬٤٦٧ | ٤٠٬٩٣٣ | ٣٣٫٣٣ | ||||
2014-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ٦١٬٤٠٠ | ٦١٬٤٠٠ | |||||
2014-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٣٧٬٧٦٧ | ٠ | ١٠٠٫٠٠ | ||||
2014-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٢٠٬٤٦٧ | ١٣٢٬٩٧٨ | ١٨٫١٩ | ||||
2014-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣٧٬٧٦٧ | ١٢٩٬٦١٩ | ٤١٫١٢ | ||||
2013-07-29 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ٧٥٬٠٠٠ | ٧٥٬٠٠٠ | |||||
2013-07-29 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٥٬٠٨٢ | ٩١٬٨٥٢ | ٥٫٨٦ | ٧٫٨١ | ٣٩٬٦٩٠ | ٧١٧٬٣٦٤ | |
2013-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ٧٧٬٥٠٠ | ٧٧٬٥٠٠ | |||||
2013-02-25 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
A - Award | ١٠٦٬٠٠٠ | ١٠٦٬٠٠٠ | |||||
2013-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٣٧٬٧٦٧ | ٣٧٬٧٦٨ | ٥٠٫٠٠ | ||||
2013-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
F - Taxes | ١٦٬٤١٠ | ٨٦٬٧٧٠ | ١٥٫٩٠ | ١٠٫٥٩ | ١٧٣٬٧٨٢ | ٩١٨٬٨٩٤ | |
2013-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣٧٬٧٦٧ | ١٠٣٬١٨٠ | ٥٧٫٧٤ | ||||
2013-01-03 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ١٬٥٠٠ | ٦٥٬٤١٣ | ٢٫٢٤ | ||||
2012-11-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
P - Purchase | ٢٬٠٠٠ | ٦٦٬٩١٣ | ٣٫٠٨ | ٩٫١٣ | ١٨٬٢٦٠ | ٦١٠٬٩١٦ | |
2012-11-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٣٬٢٧٧ | ٦٤٬٩١٣ | ٥٫٣٢ | ٥٫٤٨ | ١٧٬٩٥٨ | ٣٥٥٬٧٢٣ | |
2012-11-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
A - Award | ٢٬٥٢٨ | ٦١٬٦٣٦ | ٤٫٢٨ | ٥٫٤٨ | ١٣٬٨٥٣ | ٣٣٧٬٧٦٥ | |
2012-11-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٩٩٥ | ٥٩٬١٠٨ | ١٫٦٦ | ||||
2012-11-02 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٢٬١١٥ | ٦٠٬١٠٣ | ٣٫٤٠ | ||||
2012-02-29 |
|
4 | EXAS |
EXACT SCIENCES CORP
Stock Option (right to buy) |
A - Award | ١٢٧٬٥٠٠ | ١٢٧٬٥٠٠ | |||||
2012-01-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
M - Exercise | ٣٧٬٧٦٧ | ٧٥٬٥٣٣ | ٣٣٫٣٣ | ||||
2012-01-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Restricted Stock Units |
A - Award | ١١٣٬٣٠٠ | ١١٣٬٣٠٠ | |||||
2012-01-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
F - Taxes | ١٦٬٤١٠ | ٦٢٬٢١٨ | ٢٠٫٨٧ | ٨٫١٢ | ١٣٣٬٢٤٩ | ٥٠٥٬٢١٠ | |
2012-01-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
M - Exercise | ٣٧٬٧٦٧ | ٧٨٬٦٢٨ | ٩٢٫٤٣ | ||||
2012-01-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٢٬٨٩٠ | ٤٠٬٨٦١ | ٦٫٦١ | ||||
2012-01-04 |
|
4 | EXAS |
EXACT SCIENCES CORP
Common Stock |
G - Gift | ٢٬٩١٩ | ٤٣٬٧٥١ | ٦٫٢٥ |